IBDEI02F ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2721,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2721,1,1,0)
 ;;=1^V10.03
 ;;^UTILITY(U,$J,358.3,2721,1,8,0)
 ;;=8^Hx-Esophageal Malignancy
 ;;^UTILITY(U,$J,358.3,2721,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,2722,0)
 ;;=V10.07^^26^195^10
 ;;^UTILITY(U,$J,358.3,2722,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2722,1,1,0)
 ;;=1^V10.07
 ;;^UTILITY(U,$J,358.3,2722,1,8,0)
 ;;=8^Hx Of Liver Malignancy
 ;;^UTILITY(U,$J,358.3,2722,2)
 ;;=^295209
 ;;^UTILITY(U,$J,358.3,2723,0)
 ;;=V10.06^^26^195^30
 ;;^UTILITY(U,$J,358.3,2723,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2723,1,1,0)
 ;;=1^V10.06
 ;;^UTILITY(U,$J,358.3,2723,1,8,0)
 ;;=8^Hx-Rectal   Anal Malign
 ;;^UTILITY(U,$J,358.3,2723,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,2724,0)
 ;;=V10.04^^26^195^7
 ;;^UTILITY(U,$J,358.3,2724,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2724,1,1,0)
 ;;=1^V10.04
 ;;^UTILITY(U,$J,358.3,2724,1,8,0)
 ;;=8^Hx Of Gastric Malignancy
 ;;^UTILITY(U,$J,358.3,2724,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,2725,0)
 ;;=V10.09^^26^195^8
 ;;^UTILITY(U,$J,358.3,2725,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2725,1,1,0)
 ;;=1^V10.09
 ;;^UTILITY(U,$J,358.3,2725,1,8,0)
 ;;=8^Hx Of Gi Malignancy Nec
 ;;^UTILITY(U,$J,358.3,2725,2)
 ;;=^295210
 ;;^UTILITY(U,$J,358.3,2726,0)
 ;;=V10.01^^26^195^13
 ;;^UTILITY(U,$J,358.3,2726,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2726,1,1,0)
 ;;=1^V10.01
 ;;^UTILITY(U,$J,358.3,2726,1,8,0)
 ;;=8^Hx Of Tongue Malignancy
 ;;^UTILITY(U,$J,358.3,2726,2)
 ;;=^295203
 ;;^UTILITY(U,$J,358.3,2727,0)
 ;;=V10.02^^26^195^28
 ;;^UTILITY(U,$J,358.3,2727,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2727,1,1,0)
 ;;=1^V10.02
 ;;^UTILITY(U,$J,358.3,2727,1,8,0)
 ;;=8^Hx-Oral/Pharynx Malg Nec
 ;;^UTILITY(U,$J,358.3,2727,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,2728,0)
 ;;=V10.22^^26^195^27
 ;;^UTILITY(U,$J,358.3,2728,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2728,1,1,0)
 ;;=1^V10.22
 ;;^UTILITY(U,$J,358.3,2728,1,8,0)
 ;;=8^Hx-Nose/Ear/Sinus Malig
 ;;^UTILITY(U,$J,358.3,2728,2)
 ;;=^295215
 ;;^UTILITY(U,$J,358.3,2729,0)
 ;;=V10.11^^26^195^14
 ;;^UTILITY(U,$J,358.3,2729,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2729,1,1,0)
 ;;=1^V10.11
 ;;^UTILITY(U,$J,358.3,2729,1,8,0)
 ;;=8^Hx-Bronchogenic Malignan
 ;;^UTILITY(U,$J,358.3,2729,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,2730,0)
 ;;=V10.12^^26^195^33
 ;;^UTILITY(U,$J,358.3,2730,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2730,1,1,0)
 ;;=1^V10.12
 ;;^UTILITY(U,$J,358.3,2730,1,8,0)
 ;;=8^Hx-Tracheal Malignancy
 ;;^UTILITY(U,$J,358.3,2730,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,2731,0)
 ;;=V10.21^^26^195^21
 ;;^UTILITY(U,$J,358.3,2731,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2731,1,1,0)
 ;;=1^V10.21
 ;;^UTILITY(U,$J,358.3,2731,1,8,0)
 ;;=8^Hx-Laryngeal Malignancy
 ;;^UTILITY(U,$J,358.3,2731,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,2732,0)
 ;;=V10.29^^26^195^20
 ;;^UTILITY(U,$J,358.3,2732,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2732,1,1,0)
 ;;=1^V10.29
 ;;^UTILITY(U,$J,358.3,2732,1,8,0)
 ;;=8^Hx-Intrathoracic Mal Nec
 ;;^UTILITY(U,$J,358.3,2732,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,2733,0)
 ;;=V10.87^^26^195^12
 ;;^UTILITY(U,$J,358.3,2733,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2733,1,1,0)
 ;;=1^V10.87
 ;;^UTILITY(U,$J,358.3,2733,1,8,0)
 ;;=8^Hx Of Thyroid Malignancy
 ;;^UTILITY(U,$J,358.3,2733,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,2734,0)
 ;;=V10.51^^26^195^1
 ;;^UTILITY(U,$J,358.3,2734,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2734,1,1,0)
 ;;=1^V10.51
 ;;^UTILITY(U,$J,358.3,2734,1,8,0)
 ;;=8^Hx Of Bladder Malignancy
 ;;^UTILITY(U,$J,358.3,2734,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,2735,0)
 ;;=V10.52^^26^195^9
 ;;^UTILITY(U,$J,358.3,2735,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2735,1,1,0)
 ;;=1^V10.52
 ;;^UTILITY(U,$J,358.3,2735,1,8,0)
 ;;=8^Hx Of Kidney Malignancy
 ;;^UTILITY(U,$J,358.3,2735,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,2736,0)
 ;;=V10.46^^26^195^29
 ;;^UTILITY(U,$J,358.3,2736,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2736,1,1,0)
 ;;=1^V10.46
 ;;^UTILITY(U,$J,358.3,2736,1,8,0)
 ;;=8^Hx-Prostatic Malignancy
 ;;^UTILITY(U,$J,358.3,2736,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,2737,0)
 ;;=V10.47^^26^195^32
 ;;^UTILITY(U,$J,358.3,2737,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2737,1,1,0)
 ;;=1^V10.47
 ;;^UTILITY(U,$J,358.3,2737,1,8,0)
 ;;=8^Hx-Testicular Malignancy
 ;;^UTILITY(U,$J,358.3,2737,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,2738,0)
 ;;=V10.49^^26^195^23
 ;;^UTILITY(U,$J,358.3,2738,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2738,1,1,0)
 ;;=1^V10.49
 ;;^UTILITY(U,$J,358.3,2738,1,8,0)
 ;;=8^Hx-Male Genit Malig Nec
 ;;^UTILITY(U,$J,358.3,2738,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,2739,0)
 ;;=V10.45^^26^195^24
 ;;^UTILITY(U,$J,358.3,2739,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2739,1,1,0)
 ;;=1^V10.45
 ;;^UTILITY(U,$J,358.3,2739,1,8,0)
 ;;=8^Hx-Male Genit Malig Nos
 ;;^UTILITY(U,$J,358.3,2739,2)
 ;;=^295223
 ;;^UTILITY(U,$J,358.3,2740,0)
 ;;=V10.3^^26^195^4
 ;;^UTILITY(U,$J,358.3,2740,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2740,1,1,0)
 ;;=1^V10.3
 ;;^UTILITY(U,$J,358.3,2740,1,8,0)
 ;;=8^Hx Of Breast Malignancy
 ;;^UTILITY(U,$J,358.3,2740,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,2741,0)
 ;;=V10.41^^26^195^15
 ;;^UTILITY(U,$J,358.3,2741,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2741,1,1,0)
 ;;=1^V10.41
 ;;^UTILITY(U,$J,358.3,2741,1,8,0)
 ;;=8^Hx-Cervical Malignancy
 ;;^UTILITY(U,$J,358.3,2741,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,2742,0)
 ;;=V10.42^^26^195^34
 ;;^UTILITY(U,$J,358.3,2742,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2742,1,1,0)
 ;;=1^V10.42
 ;;^UTILITY(U,$J,358.3,2742,1,8,0)
 ;;=8^Hx-Uterus Malignancy Nec
 ;;^UTILITY(U,$J,358.3,2742,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,2743,0)
 ;;=V10.43^^26^195^11
 ;;^UTILITY(U,$J,358.3,2743,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2743,1,1,0)
 ;;=1^V10.43
 ;;^UTILITY(U,$J,358.3,2743,1,8,0)
 ;;=8^Hx Of Ovarian Malignancy
 ;;^UTILITY(U,$J,358.3,2743,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,2744,0)
 ;;=V10.44^^26^195^18
 ;;^UTILITY(U,$J,358.3,2744,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2744,1,1,0)
 ;;=1^V10.44
 ;;^UTILITY(U,$J,358.3,2744,1,8,0)
 ;;=8^Hx-Female Genit Malg Nec
 ;;^UTILITY(U,$J,358.3,2744,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,2745,0)
 ;;=V10.81^^26^195^2
 ;;^UTILITY(U,$J,358.3,2745,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2745,1,1,0)
 ;;=1^V10.81
 ;;^UTILITY(U,$J,358.3,2745,1,8,0)
 ;;=8^Hx Of Bone Malignancy
 ;;^UTILITY(U,$J,358.3,2745,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,2746,0)
 ;;=V10.82^^26^195^25
 ;;^UTILITY(U,$J,358.3,2746,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2746,1,1,0)
 ;;=1^V10.82
 ;;^UTILITY(U,$J,358.3,2746,1,8,0)
 ;;=8^Hx-Malig Skin Melanoma
 ;;^UTILITY(U,$J,358.3,2746,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,2747,0)
 ;;=V10.83^^26^195^31
 ;;^UTILITY(U,$J,358.3,2747,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2747,1,1,0)
 ;;=1^V10.83
 ;;^UTILITY(U,$J,358.3,2747,1,8,0)
 ;;=8^Hx-Skin Malignancy Nec
 ;;^UTILITY(U,$J,358.3,2747,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,2748,0)
 ;;=V10.84^^26^195^6
 ;;^UTILITY(U,$J,358.3,2748,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2748,1,1,0)
 ;;=1^V10.84
 ;;^UTILITY(U,$J,358.3,2748,1,8,0)
 ;;=8^Hx Of Eye Malignancy
 ;;^UTILITY(U,$J,358.3,2748,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,2749,0)
 ;;=V10.85^^26^195^3
 ;;^UTILITY(U,$J,358.3,2749,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2749,1,1,0)
 ;;=1^V10.85
 ;;^UTILITY(U,$J,358.3,2749,1,8,0)
 ;;=8^Hx Of Brain Malignancy
 ;;^UTILITY(U,$J,358.3,2749,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,2750,0)
 ;;=V10.86^^26^195^26
 ;;^UTILITY(U,$J,358.3,2750,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2750,1,1,0)
 ;;=1^V10.86
 ;;^UTILITY(U,$J,358.3,2750,1,8,0)
 ;;=8^Hx-Malign Nerve Syst Nec
 ;;^UTILITY(U,$J,358.3,2750,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,2751,0)
 ;;=V10.88^^26^195^16
 ;;^UTILITY(U,$J,358.3,2751,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2751,1,1,0)
 ;;=1^V10.88
 ;;^UTILITY(U,$J,358.3,2751,1,8,0)
 ;;=8^Hx-Endocrine Malign Nec
 ;;^UTILITY(U,$J,358.3,2751,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,2752,0)
 ;;=238.0^^26^196^1
 ;;^UTILITY(U,$J,358.3,2752,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2752,1,1,0)
 ;;=1^238.0
 ;;^UTILITY(U,$J,358.3,2752,1,8,0)
 ;;=8^Bone and Articular Cartilage
 ;;^UTILITY(U,$J,358.3,2752,2)
 ;;=^81953
 ;;^UTILITY(U,$J,358.3,2753,0)
 ;;=238.1^^26^196^3
 ;;^UTILITY(U,$J,358.3,2753,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2753,1,1,0)
 ;;=1^238.1
 ;;^UTILITY(U,$J,358.3,2753,1,8,0)
 ;;=8^Connective and Oth Soft Tissue
 ;;^UTILITY(U,$J,358.3,2753,2)
 ;;=^267776
 ;;^UTILITY(U,$J,358.3,2754,0)
 ;;=238.2^^26^196^17
 ;;^UTILITY(U,$J,358.3,2754,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2754,1,1,0)
 ;;=1^238.2
 ;;^UTILITY(U,$J,358.3,2754,1,8,0)
 ;;=8^Skin
 ;;^UTILITY(U,$J,358.3,2754,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,2755,0)
 ;;=238.3^^26^196^2
 ;;^UTILITY(U,$J,358.3,2755,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2755,1,1,0)
 ;;=1^238.3
 ;;^UTILITY(U,$J,358.3,2755,1,8,0)
 ;;=8^Breast
 ;;^UTILITY(U,$J,358.3,2755,2)
 ;;=^81956
 ;;^UTILITY(U,$J,358.3,2756,0)
 ;;=238.4^^26^196^15
 ;;^UTILITY(U,$J,358.3,2756,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2756,1,1,0)
 ;;=1^238.4
 ;;^UTILITY(U,$J,358.3,2756,1,8,0)
 ;;=8^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,2756,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,2757,0)
 ;;=238.5^^26^196^6
 ;;^UTILITY(U,$J,358.3,2757,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2757,1,1,0)
 ;;=1^238.5
 ;;^UTILITY(U,$J,358.3,2757,1,8,0)
 ;;=8^Histiocytic and Mast Cells
 ;;^UTILITY(U,$J,358.3,2757,2)
 ;;=^267778
 ;;^UTILITY(U,$J,358.3,2758,0)
 ;;=238.6^^26^196^14
 ;;^UTILITY(U,$J,358.3,2758,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2758,1,1,0)
 ;;=1^238.6
 ;;^UTILITY(U,$J,358.3,2758,1,8,0)
 ;;=8^Plasma Cells
 ;;^UTILITY(U,$J,358.3,2758,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,2759,0)
 ;;=238.71^^26^196^4
 ;;^UTILITY(U,$J,358.3,2759,1,0)
 ;;=^358.31IA^8^2
